Events
Nerviano Medical Sciences S.r.l. Announces Clinical Data on NMS-03592088 selected for Oral Presentation at AACR Annual Meeting 2023
NERVIANO, 4 April 2023 – Nerviano Medical Sciences Srl (Company), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that data from the Phase I/II clinical study of NMS-03592088 in Acute Myeloid Leukemia will be reported in an oral presentation by Dr. Antonio Curti, MD, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna, at the upcoming AACR Annual Meeting which will be held April 14 – 19, Orange County Convention Center, Orlando, Florida.
(Click the title for the complete article)
Visit Accelera Team at the SOT 2023 Annual Meeting in Nashville, Tennessee (March 19-23)
Visit Accelera Team
at the SOT 2023 Annual Meeting in Nashville, Tennessee
March 19 – 23
Booth #1214
Visit our booth for an overview of our services
(Click the title for the complete article)
Accelera sponsor del 21° congresso nazionale SITOX – Bologna (20-22 Febbraio 2023)
Accelera è Sponsor del 21° congresso nazionale SITOX che si svolgerà a Bologna il giorno 21 febbraio (dalle 11.00 alle 12.00), presenterà il poster “Valutazione preclinica della tossicità a carico del SNC nel soggetto pediatrico: tecniche istologiche in neonati di ratto”.
nella sessione P3 Farmaci
Numero del poster: P3/1
(Click the title for the complete article)
Nerviano Medical Sciences S.r.l. Shared Data on NMS-01940153E selected for Oral Presentation at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Nerviano Medical Sciences Srl (Company), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today shared data from the Company’s Phase I/II clinical study of NMS-01940153E in Hepatocellular carcinoma (HCC) in an oral presentation by Dr. Maria Reig at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2022) in Barcelona.
(Click the title for the complete article)
Nerviano Medical Sciences S.r.l. Announces a Poster Presentation on NMS-03602173 at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Nerviano Medical Sciences Srl, a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that preclinical data from the Company’s asset NMS-03602173 will be reported in a poster presentation by Dr. Paola Magnaghi at the upcoming EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2022) which will be held October 26-28, 2022 at the CCIB in Barcelona.
(Click the title for the complete article)
NMS-01940153E selected for Oral Presentation at 34th EORTC-NCI-AACR
NERVIANO, 18 October 2022 – Nerviano Medical Sciences Srl (Company), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that data from the Company’s Phase I/II clinical study of NMS-01940153E in Hepatocellular carcinoma (HCC) will be reported in an oral presentation by Dr. Maria Reig at the upcoming EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2022) which will be held October 26-28, 2022 at the CCIB in Barcelona.
(Click the title for the complete article)
We are ICT in Maastricht 2022
Where: MECC – Forum 100, 6229 GV Maastricht, Netherlands
When: September 18 to 21, 2022
The Dutch Society of Toxicology (NVT) is welcoming the global community to the XVIth International Congress of Toxicology in Maastricht, the Netherlands, from September 18 to 21, 2022.
Accelera s.r.l. will be present at the ICT in Maastricht Exhibition Booth # 37.
We look forward to see you soon!
Get an appointment with us! E-mail: Francesco.Sola@accelera.org
Science, democracy and animal experimentation: the need for a debate- Sept 13th, 2.30-3.30 pm
Dr. Simone Pollo main research interests are the ethics of human/animal relationships and the naturalization of ethics. He is MA in Philosophy at Sapienza University of Rome (1995) and PhD in Bioethics at the University of Genoa (2011). He is currently Associate Professor of Moral Philosophy at the Department of Philosophy of Sapienza University of Rome, where teaches “Ethics and Life Sciences” and “Bioethics” and is a member of the board of the PhD program in Philosophy.(Click the title for the complete article)
CPhI Worldwide
Where: Fiera Milano, Milan, Italy
When: 9 November – 11 November 2021
CPhI Worldwide 2021 has established itself as the flagship event for the pharmaceutical industry. The upcoming edition will be staged from 9th to 11th November at Fiera Milano.
NMS Group is participating for the first time as an integrated, fully fledged R&D organization. We will be exhibiting in the featured area of ICSE where outsourcing providers, from contract manufacturing, research to services are all gathered in one place.
Biotech Week 2021 Webinar in Italian: Sviluppo di farmaci in ambito Oncologico
Where: Zoom webinar
When: Friday 1 October 4.30 PM
We are pleased to invite you to our webinar entitled “Development of drugs in the oncology field (in Italian)” which will be held on 1 October at 4.30 PM via Zoom among more than 100 events held during the European Biotech week 2021.